Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

Mice Heterozygous for Blm Mutation have Increased Tumor Development

Joanna Groden
University of Cincinnati College of Medicine, and Howard Hughes Medical Institute
P30ES06096

Background: In traditional Mendelian genetics, dominant and recessive genes exist. For example, the gene for blue eyes is recessive while the gene for brown eyes is dominant. If a person inherits one allele for blue eyes from one parent and one for brown from the other parent, he is said to be heterozygous and in this case, since the blue-eyed gene is recessive, he will have brown eyes.

In cancer biology, there are many tumor suppressor and DNA repair genes that are dominant. Therefore, heterozygous animals are sufficiently protected against certain cancers. The gene controlling the formation of Bloom syndrome is a DNA repair gene known as Blm. Bloom syndrome is characterized by small stature, male infertility, a compromised immune system, and increased risk for a variety of tumors including colorectal cancer.

Advance: Researchers at the University of Cincinnati supported jointly by NIEHS, NCI, and the Howard Hughes Medical Institute, report that contrary to the traditional Mendelian inheritance pattern described above, mice heterozygous for Blm are at higher risk for cancer development. When challenged with murine leukemia virus, heterozygous mice developed lymphoma earlier than wild-type mice. Also, when cross matings were performed with mice susceptible to intestinal tumors, heterozygous offspring developed twice the number of intestinal tumors.

Implication: These findings describe the increased risk and genetic mechanism for intestinal cancer development in mice heterozygous for Blm and have implications for cancer risk in humans. In fact, a companion paper published in the same journal describes an epidemiologic study of Ashkenazi Jews which reports that people heterozygous for the same allele were more than twice as likely to develop colorectal cancer as control subjects.

Citations:

USA.gov Department of Health & Human Services National Institutes of Health
This page URL: http://www.niehs.nih.gov/research/supported/sep/2002/blm.cfm
NIEHS website: http://www.niehs.nih.gov/
Email the Web Manager at webmanager@niehs.nih.gov
Last Reviewed: May 15, 2007